Braxia Scientific Corp (BRAXF)
0.0054
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Braxia Scientific Shareholders Equity (Quarterly): -0.2758M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.2758M |
September 30, 2023 | 0.3937M |
June 30, 2023 | 0.6066M |
March 31, 2023 | 1.186M |
December 31, 2022 | 5.850M |
September 30, 2022 | 7.634M |
June 30, 2022 | 6.368M |
March 31, 2022 | 7.179M |
December 31, 2021 | 10.00M |
Date | Value |
---|---|
September 30, 2021 | 11.24M |
June 30, 2021 | 12.23M |
March 31, 2021 | 12.59M |
December 31, 2020 | 14.45M |
September 30, 2020 | 14.91M |
June 30, 2020 | 16.00M |
March 31, 2020 | 9.867M |
December 31, 2019 | 0.7339M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-0.2758M
Minimum
Dec 2023
16.00M
Maximum
Jun 2020
7.704M
Average
7.634M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
Acasti Pharma Inc | 64.68M |
Aurinia Pharmaceuticals Inc | 377.95M |
Edesa Biotech Inc | 4.324M |
Lexaria Bioscience Corp | 6.521M |
Xenon Pharmaceuticals Inc | 887.70M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.763M |
Total Liabilities (Quarterly) | 2.038M |
Debt to Equity Ratio | -0.2955 |
Current Ratio | 0.1802 |
Net Debt Paydown Yield | 6.85% |